|
| 百克生物(688276)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-06-25 | 17148.82 | 41.54% | 41284.07 | 0.00 | 24118.27 | 58.42% | 首发原股东限售股份 | | 2024-04-30 | 81.69 | 0.20% | 24216.94 | 17148.82 | 24216.94 | 58.54% | 股权激励一般股份 | | 2023-06-26 | 165.06 | 0.40% | 24135.25 | 17148.82 | 24118.27 | 58.42% | 首发战略配售股份 | | 2023-05-26 | 616.84 | 1.49% | 24118.27 | 17165.80 | 23501.43 | 56.93% | 首发原股东限售股份 | | 2022-06-27 | 20050.55 | 48.57% | 23353.35 | 17930.72 | 23353.35 | 56.57% | 首发原股东限售股份,首发战略配售股份 | | 2021-12-27 | 160.31 | 0.39% | 3464.80 | 37819.27 | 3464.80 | 8.39% | 首发机构配售股份 |
|